Immunotherapy of Human leukemia with Neuraminidase-Modified Cells
- 1 May 1976
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 60 (3) , 539-549
- https://doi.org/10.1016/s0025-7125(16)31896-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cellsInternational Journal of Cancer, 1974
- Combined Chemotherapy and Immunotherapy of Transplantable and Spontaneous Murine Leukemia in DBA/2 and AKR MicePublished by Springer Nature ,1974
- Neuraminidase Induced Loss in the Transplantability of Murine Leukaemia L 1210, Induction of Immunoprotection and the Transfer of Induced Immunity to Normal DBA/2 Mice by Serum and Peritoneal CellsBritish Journal of Cancer, 1973
- Immunospecific Regression of Methylcholanthrene Fibrosarcoma Using NeuraminidaseAnnals of Surgery, 1972
- LOSS OF WEAK ANTIGENICITY OF LYMPHOMA CELLS FOLLOWING TREATMENT WITH DIFLUORO- DINITROBENZENETransplantation, 1970
- The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumourBritish Journal of Cancer, 1968
- Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with NeuraminidaseNature, 1968
- AN ALTERATION IN TUMOR HISTOCOMPATIBILITY INDUCED BY NEURAMINIDASETransplantation, 1967
- Induction of Tumour Immunity with Tumour Cells Treated with IodoacetateNature, 1966